Athira Pharma, Inc.
General ticker "ATHA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $155.8M (TTM average)
Athira Pharma, Inc. follows the US Stock Market performance with the rate: 29.8%.
Estimated limits based on current volatility of 4.4%: low 3.85$, high 4.20$
Factors to consider:
- Total employees count: 26 (-61.2%) as of 2024
- Top business risk factors: Development delays of ATH 1105, Regulatory and compliance, Strategic risks and growth management, Litigation risks, Liquidity and credit risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.01$, 12.06$]
- 2025-12-31 to 2026-12-31 estimated range: [2.23$, 8.25$]
Short-term ATHA quotes
Long-term ATHA plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $100.90MM |
| Operating Income | $-100.90MM |
| Non-Operating Income | $3.96MM |
| R&D Expense | $70.68MM |
| Income(Loss) | $-96.94MM |
| Profit(Loss)* | $-96.94MM |
| Stockholders Equity | $44.84MM |
| Assets | $58.78MM |
| Operating Cash Flow | $-97.17MM |
| Capital expenditure | $0.03MM |
| Investing Cash Flow | $54.83MM |
| Financing Cash Flow | $0.19MM |
| Earnings Per Share** | $-25.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.